Base Formation · 2026-06-25 · Pharmaceuticals & Drugs
MARKSANS
Marksans Pharma Ltd.
Strong momentum structure
Setup readiness
Early Trend
- Pivot Levels
- ₹265.6-267.9
- Support Level
- ₹244.0
- Resistance
- ₹319.9
- Risk Distance
- 8.9% to stop
Reference levels for educational study only. Not a recommendation to buy or sell.
Swing Edge Intelligence
Structured setup analysis · research only
Setup status · Strong leadership structure
Trend, relative strength and setup quality align with leading momentum names.
Bullish factors
- MACD below zero — weak trend (−2).
- Volume quality 32 weak (-5).
- Price is approaching the pivot zone.
- ATR 4.7%/day — healthy volatility (+4).
- ATR shrinking 3 consecutive weeks — coil forming.
- Action-ready zone: RS and pivot distance aligned (+5).
- Quality decay ×0.96 on raw 108 → 104.
- RS ×0.96 (rank 85).
- Recent volume expansion — institutional participation may be returning.
- Volume flow suggests quiet institutional accumulation.
- Volume persistence 0/3 — capped at Strong.
- Accumulation/Distribution rating supports institutional demand.
Risk factors
- Stop is 9% away — too wide to size well for a swing
Overall view
Short-term accumulation is visible, though it should be weighed against trend and RS context. Leadership metrics are generally constructive, but select risk factors below deserve attention.
Setup research
MARKSANS — trend, RS & risk snapshot (not a trade recommendation)
Signal · context · invalidation · risk · skip reasons — research only
Positives
Coiled at the pivot — breakout trigger is imminent
- RS line at new highs — leadership intact
- Confirmed Stage 2 uptrend
Context & regime
- Market regime Mixed / range-bound
- Trend stage Stage 2 — tradable
- Sector Mid-pack (#20/40)
- Relative strength Leader (RS 85)
- Trend strength Strong (ADX 39)
Negatives
This idea is wrong below ₹244.0 (4.7% away)
Base / stop support breaks — the swing thesis is wrong below here
- Stop / base low₹244.0
- Pivot — failure re-entry below₹266.5
Risk distance
Risk ≈ ₹23.86/share from entry ₹267.9.
Stop is wide (9%) for a swing — sizing will be small
Reasons to skip 1
Disqualifiers that apply even if the score looks good.
- Stop is 9% away — too wide to size well for a swing
Setup metrics Base Formation
MARKSANS Technical Analysis & Swing Setup
Grouped structure, momentum and risk from the latest base formation scan.
Structure
Momentum
Risk
More scanner fields
MARKSANS Support & Resistance Levels
Research chart
Daily price action with pivot, support, and resistance levels from our latest scan, plus relative strength vs Nifty.
Pivot levels, support and resistance are drawn on the price chart. · Research only.
Sector RS rank · latest scan
Loading peer comparison…
Seasonality — monthly returns
How this stock moved month by month over the last ~2 years.
A rough tendency, not a reliable pattern. Research only, not advice.
AI insights
AI Insights
Generated with AIThese insights are AI-generated to support your research process and should not be treated as investment advice or a recommendation to buy or sell securities.
Sign in to unlock AI Insights
Personalised swing trade analysis powered by Gemini AI
Pattern context 52w · setup · flow
52-week range
—Stage-2 ideal band · Early recovery
Pattern highlights
Pattern signals from the latest scan
Smart money flow
Last 60 sessions · accumulation vs distribution
Setup intelligence Overhead · VCP · radar · risk
Overhead supply
Resistance ceiling above current price
Chase / failure risk
Honest read on exhaustion & extended moves
Base / VCP coil
Depth, contractions & pivot distance
Setup quality radar
Shape of the setup in one view
Peer comparison Sector peers
Sector Peer Comparison
Loading sector peers…
MARKSANS FAQ Common swing-trading questions
Frequently asked questions about MARKSANS
What are the screener observations for MARKSANS?
On Swing Edge's swing-setup framework, Marksans Pharma Ltd. (MARKSANS) currently grades B — workable setup. Coiled at the pivot — breakout trigger is imminent. Flagged today. This is educational research, not investment advice.
What are MARKSANS's support and resistance levels?
For MARKSANS, near-term support sits around ₹244.0 (the base/stop zone); overhead resistance is around ₹266.5 (the breakout pivot); the next resistance above is ₹319.9. This is educational research, not investment advice.
What is the breakout / pivot level for MARKSANS?
The breakout pivot for MARKSANS is around ₹266.5. Price is about 3.9% below the pivot and still building toward it. A breakout is typically confirmed on a close above the pivot with above-average volume. This is educational research, not investment advice.
Is MARKSANS above its 50-day and 200-day moving averages?
Yes — MARKSANS is in a confirmed Stage 2 uptrend, trading above its rising 50- and 200-day moving averages, the zone where swing setups tend to work best. This is educational research, not investment advice.
How strong is MARKSANS versus the market (RS rank)?
MARKSANS has a relative strength (RS) rank of 85 out of 100 versus the NSE universe, making it a market leader — stronger than most NSE stocks. Trend strength (ADX) reads 39, indicating a strong trend. This is educational research, not investment advice.
Answers are generated from Swing Edge's latest scan data and are for research only — not investment advice.
Prices and day-change figures use the last daily close from scan data dated 2026-06-25 — not live intraday NSE quotes.